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Background: Rikkunshito is a traditional Japanese herbal medicine that is used to treat appetite loss associated
with cancer and other disorders. The formulation contains various constituents that influence cell signaling, and
rikkunshito may accordingly affect human homeostasis through multiple regulatory pathways, including those
governed by the endocrine system. We investigated the actions of rikkunshito on catecholamine release from PC12
cells, an adrenal chromaffin cell line.
Methods: The actions of rikkunshito on PC12 cells were evaluated by measuring intracellular cAMP levels, tyrosine
hydroxylase (TH) and vasoactive intestinal peptide (VIP) mRNA expression levels, and catecholamine levels in the
culture medium. The transcriptional activation of VIP gene by rikkunshito was assessed by using a VIP promoter-
driven reporter gene assay.
Results: Rikkunshito dose-dependently enhanced forskolin-induced elevations in cAMP in PC12 cells, and also
increased the gene expression of TH and VIP. The transcriptional activation of VIP gene by rikkunshito was confirmed.
Norepinephrine and dopamine secretion into the culture medium of PC12 cells were also dose-dependently augmented
by rikkunshito and/or forskolin, but experiments with a protein kinase C (PKC) activator and a phosphodiesterase
inhibitor revealed that the effects of rikkunshito were not simply due to the modulation of PKC or phosphodiesterase
activity.
Conclusions: These findings suggest that rikkunshito enhances the release of catecholamines by a novel mechanism
involving cAMP.
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Rikkunshito is a traditional Japanese herbal medicine
that is used to treat various symptoms of dyspepsia, in-
cluding appetite loss, nausea, vomiting, and epigastric
distention [1-4]. Rikkunshito is not commonly associated
with serious adverse effects; hence, this formulation has
recently received attention for the management of
cancer-related conditions, such as cancer cachexia [5-8].
Rikkunshito (Japan standard commodity classification
No. 875200) consists of eight crude drugs: Atractylodis
lanceae rhizoma (atractylodes lancea rhizome, 18.6%* Correspondence: ttsukada@ncc.go.jp
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distribution, and reproduction in any medium(w/w)), Poria (poria sclerotium, 18.6%), Ginseng radix
(ginseng, 18.6%), Pinelliae tuber (pinellia tuber, 18.6%),
Aurantii nobilis pericarpium (citrus unshiu peel, 9.3%),
Zizyphi fructus (jujube, 9.3%), Zingiberis rhizoma (ginger,
2.3%), and Glycyrrhizae radix (glycyrrhiza, 4.7%). Because
many of these herbal constituents influence cell signaling,
rikkunshito may affect human homeostasis through mul-
tiple regulatory pathways, including the endocrine system.
PC12 cells are derived from a pheochromocytoma of
the rat adrenal medulla and display the characteristics of
adrenal chromaffin cells. PC12 cells are therefore often
used as a model of the adrenal medulla in pharmaco-
logical studies [9]. These cells contain endogenous cate-
cholamines that are released in response to distinct
stimuli, including various herbal medicine components.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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medicine, increases dopamine release from PC12 cells
[10]. On the other hand, hirsuteine, a compound isolated
from a Japanese herb of the Uncaria genus, antagonizes
the nicotine-evoked secretion of dopamine [11]. In
addition, extracts of ginseng, a component of rikkunshito,
suppress the gene expression of enzymes involved in
dopamine and norepinephrine synthesis in PC12 cells
[12]. However, in spite of extensive studies utilizing PC12
cells, the effects of rikkunshito itself on the synthesis and/
or release of catecholamines have never before been docu-
mented. We have been interested in the influences of
Japanese herbal medicine on the endocrine system and ex-
amined the effects of rikkunshito on endocrine cells. We
now report that rikkunshito stimulates the release of nor-
epinephrine and dopamine from PC12 cells via a novel
mechanism involving cAMP.Methods
Rikkunshito stock solution
Rikkunshito was kindly supplied by Tsumura and Co.
(Tokyo, Japan) as a spray-dried powder derived from a hot
water extract of crude drugs. The spray-dried powder
(10 g) was resuspended in hot water (100 ml), and the
supernatant was filtered through a 0.45 μm sterile mem-
brane (Millipore, Ireland). Phosphate buffered saline (10×
stock solution, 1:9 v/v) was added to the filtrate to prepare
the rikkunshito stock solution. Aliquots of the rikkunshito
stock solution were stored at −30°C until use.Cells
PC12-VG cells were previously established by the stable
transfection of the β-galactosidase reporter gene tran-
scribed from the vasoactive intestinal peptide (VIP) gene
promoter into the parental rat pheochromocytoma PC12
cell line [13]. Cells were maintained in Dulbecco’s modi-
fied Eagle’s medium supplemented with 10% fetal bovine
serum (ICN Biomedicals, Inc., Aurora, OH), 5% horse
serum (Gibco, Life Technologies, Carlsbad, CA), penicillin-
streptomycin (100 U/ml penicillin and 100 μg/ml strepto-
mycin) (nacalai tesque, Kyoto, Japan), and 100 μg/ml G418
disulfate aqueous solution (nacalai tesque), as previously
described [13].Measurement of intracellular cAMP levels
Semi-confluent cells plated in 24-well plates were
treated in triplicate for 30 min with forskolin (0, 0.1, 0.3,
1, or 3 μM) (Calbiochem, Merck, Damstadt, Germany)
plus rikkunshito stock solution (0, 1, or 3%). Cells were
then subjected to a competition enzyme-linked immuno-
assay by using the cAMP XP™ assay kit (Cell Signaling
Technology, Danvers, MA).Measurement of mRNA expression levels
Semi-confluent cells plated in 60 mm tissue culture
dishes were treated in triplicate for 6 h with forskolin (0,
0.1, 0.3, 1, or 3 μM) plus rikkunshito stock solution (0
or 3%). Total RNA was extracted by using the QIAsh-
redder (Qiagen, Hilden, Germany) and the RNeasy Mini
Kit (Qiagen). First strand cDNA was prepared by using
oligo-dT primers and SuperScript III reverse transcript-
ase (Invitrogen, Life Technologies). Rat tyrosine hydrox-
ylase (TH) and rat VIP mRNA levels were measured by
using the QuantiTect SYBR Green RT-PCR assay kit
(Qiagen) and a real-time monitoring fluorescent quantita-
tive detection system (LineGene, Bioflux, Tokyo, Japan).
The mRNA levels for each gene were normalized relative
to those of glyceraldehyde-3-phosphate dehydrogenase
(G3PDH). The primer sequences were as follows: TH,
forward 5′-AGCCC AAGGG CTTCA GAAGG GC-3′,
reverse 5′-CGCTC CTTGC GGGCA TCCTC GATGA
G-3′; VIP, forward 5′-CGCTG GCCTG GCCTC TCTAT
G-3′, reverse 5-CTGCA AGATG TCAGA GTCTG C-3′;
and G3PDH, forward 5′-TGCAC CACCA ACTGC TTA
GC-3′, reverse 5′-AGTGATGGCATGGAC TGTGG-3′.Measurement of VIP gene promoter activity
Semi-confluent cells plated in a flat-bottomed 96-well
plate were treated in quadruplicate for 6 h with fresh
culture medium containing forskolin (0, 0.1, 0.3, 1, 3, or
10 μM) plus rikkunshito stock solution (0, 1, or 3%), 100
nM 12-O-tetradecanoylphorbol-13-acetate (TPA) (Wako
Pure Chemical Industries, Osaka, Japan), or 0.5 mM 3-
isobutyl-1-methylxanthine (IBMX) (Sigma-Aldrich, St.
Louis, MO). VIP gene promoter activity was determined
by assaying β-galactosidase activity with a chromogenic
substrate, measuring the absorbance at 420 nm, and
subtracting the background absorbance, as described
previously [13].Measurement of catecholamines in culture medium
Cells were treated in triplicate with forskolin (0, 0.1, or
0.3 μM) plus rikkunshito stock solution (0, 1, or 3%),
100 nM TPA, or 0.5 mM IBMX. Three hours later, ali-
quots of the culture medium were collected and stored
at −20°C until use. Catecholamine levels were analyzed
by high performance liquid chromatography.Statistical analysis
Statistical analyses of mean values in the treatment vs.
control at each forskolin concentration were performed
by two-tailed Student’s t-test. Data were expressed as
the mean ± standard error of the mean (SEM), and
P values less than 0.05 were considered statistically
significant.
Figure 1 Rikkunshito acts in synergy with forskolin to enhance
cAMP levels in PC12 cells. PC12 cells were treated with forskolin
alone or in combination with rikkunshito for 30 min. cAMP levels are
shown as total amounts for cells plated in individual wells of 24-well
plates. Data are presented as the mean ± SEM of triplicate independent
experiments. *, p < 0.05 vs. 0% rikkunshito at each forskolin concentration
tested, two-tailed Student’s t-test.
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Effects of rikkunshito on cAMP levels in PC12 cells
Forskolin, a direct activator of adenylate cyclase, dose-
dependently increased intracellular cAMP levels in PC12
cells (Figure 1), as previously reported [14]. Rikkunshito
synergistically enhanced the forskolin-induced increaseFigure 2 Rikkunshito increases TH and VIP mRNA levels. PC12 cells we
6 h. The expression levels of TH mRNA (A) and VIP mRNA (B) were normal
presented as the mean ± SEM of triplicate independent experiments. *, p <
tailed Student’s t-test.in cAMP levels in a dose-dependent manner, but had lit-
tle effect on its own.
Effects of rikkunshito on TH and VIP mRNA levels
TH and VIP mRNA expression levels were dose-
dependently augmented in PC12 cells by forskolin, in
agreement with the observations of other investigators
[13,15]. Rikkunshito (3%) also increased TH and VIP
mRNA expression levels by itself, and further enhanced
the expression levels of both mRNAs in the presence of
lower concentrations of forskolin (0.1, 0.3, and 1 μM for
TH mRNA, Figure 2A; 0.1 and 0.3 μM for VIP mRNA,
Figure 2B). However, such further enhancement of gene
expression by rikkunshito was not observed when the cells
were stimulated with forskolin at higher concentrations.
Effects of rikkunshito on VIP promoter activity
To confirm that the increased mRNA levels correspond-
ing to the cAMP-responsive TH and VIP genes were due
to enhanced transcription, VIP gene promoter activity was
measured in PC12 cells expressing the β-galactosidase
reporter gene driven by the VIP gene promoter
(PC12-VG cells). Forskolin dose-dependently stimu-
lated β-galactosidase activity in these cells, as expected
(Figure 3). Rikkunshito also dose-dependently stimulated
β-galactosidase activity, and in addition potentiated the
actions of forskolin in a dose-dependent manner
(Figure 3A). Nonetheless, rikkunshito did not increase the
maximum effects observed with forskolin at high concen-
trations (Figure 3A and B). By contrast, TPA enhanced
forskolin-induced β-galactosidase activity over the entire
range of forskolin concentrations tested, as previouslyre treated with forskolin alone or in combination with rikkunshito for
ized relative to the expression level of G3PDH mRNA. Data are
0.05 vs. 0% rikkunshito at each forskolin concentration tested, two-
Figure 3 Rikkunshito stimulates VIP promoter activity in PC12 cells. PC12 cells were treated with forskolin alone or in combination with
rikkunshito (A), or rikkunshito, TPA, or IBMX (B) for 6 h. Data are presented as the mean ± SEM of quadruplicate independent experiments. *, p < 0.05
vs. 0% rikkunshito at each forskolin concentration tested, two -tailed Student’s t-test.
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were obtained in cells treated with forskolin plus IBMX
(Figure 3B).
Effects of rikkunshito on catecholamine release from
PC12 cells
Unlike normal chromaffin cells, PC12 cells produce
norepinephrine and dopamine, but they do not pro-
duce detectable amounts of epinephrine [9]. We found
that norepinephrine (Figure 4A) and dopamine levels
(Figure 4B) were dose-dependently increased in theFigure 4 Rikkunshito promotes catecholamine release from PC12 cell
medium of PC12 cells treated with forskolin alone or in combination with
TPA, and 0.5 mM IBMX are shown in the insets. Data are presented as the
rikkunshito at each forskolin concentration tested, two-tailed Student’s t-tesculture medium of PC12 cells when the cells were stimu-
lated with forskolin, rikkunshito, or a combination of
both. The synergistic effects of forskolin (0.1 and 0.3 μM)
plus rikkunshito (1 or 3%) are clearly demonstrated in
Figure 4, and were considerably greater than those of for-
skolin plus 100 nM TPA or forskolin plus 0.5 mM IBMX.
Discussion
This study investigated the effects of rikkunshito on cat-
echolamine release from rat pheochromocytoma PC12
cells. Rikkunshito increased intracellular cAMP levels ins. Norepinephrine (A) and dopamine (B) were measured in the culture
rikkunshito, TPA, or IBMX for 3 h. Data points of 0% rikkunshito, 100 nM
mean ± SEM of triplicate independent experiments. *, p < 0.05 vs. 0%
t.
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expression of the TH and VIP genes (Figures 2 and 3),
both of which are activated by cAMP at the transcrip-
tional level [13,15]. Importantly, cAMP was previously
shown to augment catecholamine release from PC12
cells [16]. We also observed enhanced catecholamine re-
lease by rikkunshito (Figure 4), which presumably is medi-
ated at least in part by cAMP. Among eight crude drugs
of rikkunshito, ginseng and citrus unshu peel most po-
tently enhanced VIP promoter activity (our unpublished
data), suggesting that these drugs may have the com-
pounds responsible for the increase of cAMP. As ginseng
contains a substantial amount of adenosine and PC12 cells
have adenosine A2A receptor, which activates adenylate
cyclase and induces synthesis of cAMP, adenosine may be
responsible for the cAMP-inducing effect of rikkunshito.
In agreement with earlier work [13], TPA, a protein
kinase C (PKC) activator, increased the maximum ac-
tions of high concentrations of forskolin to induce VIP
gene promoter activity in PC12 cells (Figure 3). IBMX, a
phosphodiesterase inhibitor, also increased the max-
imum actions of forskolin. By contrast, rikkunshito acted
in synergy with lower concentrations of forskolin, but did
not enhance the maximum effect of higher concentrations
of forskolin. These findings suggest that rikkunshito does
not simply modulate PKC and/or phosphodiesterase activ-
ities to influence catecholamine synthesis in and/or release
from PC12 cells.
Also noteworthy is that rikkunshito by itself has little
effect on cAMP level (Figure 1), but clearly stimulated
TH and VIP gene expression and catecholamine release
(Figures 2 and 4). These findings suggest the involve-
ment of a signaling pathway other than those activated
by cAMP. Because 100 nM TPA alone and 0.5 mM
IBMX alone have only limited effects on VIP promoter
activity (Figure 3B) and catecholamine release (Figure 4),
other mechanisms than protein kinase C activation and
phosphodiesterase inhibition should be operating. A
candidate mechanism might be activation of ion chan-
nels involved in catecholamine release. Further study is
necessary to elucidate the protein kinase A and C-
independent effects of rikkunshito.
Previous studies demonstrated that ginseng signifi-
cantly reduces stress-induced elevations in TH and
dopamine β-hydroxylase (DBH) mRNA levels in the rat
adrenal gland, and that ginseng total saponin also re-
duces nicotine-induced TH and DBH gene expression in
PC12 cells [12]. Furthermore, glycyrrhetinic acid, one of
the main components of glycyrrhiza, inhibits phospho-
diesterase activity and increases intracellular cAMP
levels in various tissues in vivo [17]. While these studies
indicate that the components of rikkunshito exhibit dis-
tinct biological activities, they do not fully explain the
actions of rikkunshito demonstrated in the presentstudy. It is likely that the capacity of rikkunshito to in-
fluence cAMP levels and catecholamine metabolism in
PC12 cells stems from additive, synergistic, and antagon-
istic interactions among the diverse constituents of the
herbal formulation, rather than from the actions of any
single component.
Rikkunshito is employed as an antiemetic agent for
the management of a variety of conditions, including
chemotherapy-related dyspepsia in cancer patients [7].
Thus, rikkunshito may find utility as part of a regimen to
treat cancer cachexia, which is characterized by anorexia,
body weight loss, muscle and fat wasting, and biochemical
abnormalities related to a state of hyponutrition. Previous
work showed that muscle wasting in animal models of
cancer cachexia was diminished by β-adrenergic agonists
(e.g., formoterol and clenbuterol), with a possible mechan-
ism of action attributed to the inhibition of muscle prote-
olysis [18,19]. Rikkunshito might therefore be beneficial in
ameliorating cachexia-associated muscle wasting, if its
in vitro actions to augment catecholamine release are re-
capitulated in vivo. Further whole-animal investigations
will be required to explore this hypothesis.Conclusions
This study demonstrated for the first time that rikkunshito
increases cAMP levels and augments catecholamine re-
lease from PC12 cells through an as yet undetermined
mechanism. Elucidation of the mechanism of action of
rikkunshito will foster our understanding of the thera-
peutic efficacy of this herbal formulation.Competing interests
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